Welcome to LookChem.com Sign In|Join Free
  • or
4-Hydroxyquinoline is a hydroxylated quinoline derivative characterized by its antimicrobial activity and ability to act as sacrificial scavengers of photogenerated oxygen species, which helps prevent the photodegradation of riboflavin.

611-36-9

Post Buying Request

611-36-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

611-36-9 Usage

Uses

Used in Pharmaceutical Industry:
4-Hydroxyquinoline is used as a medical raw material for its antimicrobial properties, showing growth-inhibitory effects against intestinal bacteria.
Used in Chemical Industry:
4-Hydroxyquinoline is used as a sacrificial scavenger for photogenerated oxygen species, helping to prevent the photodegradation of riboflavin and other light-sensitive compounds.

Biological Activity

4-hydroxyquinoline is a hydroxylated quinoline derivative with antimicrobial activity. it shows growth-inhibitory effects against intestinal bacteria. it also can be used as sacrificial scavengers of the photogenerated oxygen species.

Check Digit Verification of cas no

The CAS Registry Mumber 611-36-9 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,1 and 1 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 611-36:
(5*6)+(4*1)+(3*1)+(2*3)+(1*6)=49
49 % 10 = 9
So 611-36-9 is a valid CAS Registry Number.
InChI:InChI=1/C9H7NO/c11-9-5-6-10-8-4-2-1-3-7(8)9/h1-6H,(H,10,11)

611-36-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A15859)  4-Hydroxyquinoline, 98%   

  • 611-36-9

  • 1g

  • 258.0CNY

  • Detail
  • Alfa Aesar

  • (A15859)  4-Hydroxyquinoline, 98%   

  • 611-36-9

  • 5g

  • 1031.0CNY

  • Detail
  • Alfa Aesar

  • (A15859)  4-Hydroxyquinoline, 98%   

  • 611-36-9

  • 10g

  • 2053.0CNY

  • Detail
  • Aldrich

  • (H58005)  4-Quinolinol  98%

  • 611-36-9

  • H58005-1G

  • 259.74CNY

  • Detail
  • Aldrich

  • (H58005)  4-Quinolinol  98%

  • 611-36-9

  • H58005-5G

  • 2,155.14CNY

  • Detail
  • Aldrich

  • (H58005)  4-Quinolinol  98%

  • 611-36-9

  • H58005-10G

  • 3,353.22CNY

  • Detail

611-36-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name quinolin-4-ol

1.2 Other means of identification

Product number -
Other names 4-hydroxyquinoline acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:611-36-9 SDS

611-36-9Synthetic route

4-(phenylmethoxy)quinoline
101273-58-9

4-(phenylmethoxy)quinoline

quinolin-4-ol
611-36-9

quinolin-4-ol

Conditions
ConditionsYield
With tris(bipyridine)ruthenium(II) dichloride hexahydrate; ascorbic acid In water; acetonitrile at 20℃; for 1h; Schlenk technique; Irradiation; Inert atmosphere; chemoselective reaction;99%
4-hydroxy-3-quinoline carboxylic acid
34785-11-0

4-hydroxy-3-quinoline carboxylic acid

quinolin-4-ol
611-36-9

quinolin-4-ol

Conditions
ConditionsYield
In diphenylether for 1h; Reflux;97%
7-chloro-1,2,3,4-tetrahydroquinolin-4-one
21617-15-2

7-chloro-1,2,3,4-tetrahydroquinolin-4-one

A

7-chloro-4-hydroxylquinoline
86-99-7

7-chloro-4-hydroxylquinoline

B

quinolin-4-ol
611-36-9

quinolin-4-ol

Conditions
ConditionsYield
A 88.3%
B n/a
1-methanesulfonyl-4a,8a-dihydro-1H-quinolin-4-one

1-methanesulfonyl-4a,8a-dihydro-1H-quinolin-4-one

quinolin-4-ol
611-36-9

quinolin-4-ol

Conditions
ConditionsYield
With lithium diisopropyl amide In tetrahydrofuran at 0℃; for 0.0833333h;72%
methanesulfonic acid quinolin-4-yl ester

methanesulfonic acid quinolin-4-yl ester

quinolin-4-ol
611-36-9

quinolin-4-ol

Conditions
ConditionsYield
With lithium diisopropyl amide In tetrahydrofuran at 0℃; for 0.0833333h;68%
5-(N-phenyl)-aminomethylene-2,2-dimethyl-1,3-dioxane-4,6-dione
15568-92-0

5-(N-phenyl)-aminomethylene-2,2-dimethyl-1,3-dioxane-4,6-dione

quinolin-4-ol
611-36-9

quinolin-4-ol

Conditions
ConditionsYield
In tetrahydrofuran at 300℃; under 75007.5 Torr; for 0.025h; Gould-Jacobs type cyclization; Flash vacuum pyrolysis; Autoclave; regioselective reaction;60%
1-(2-isocyanophenyl)ethan-1-one
521270-78-0

1-(2-isocyanophenyl)ethan-1-one

quinolin-4-ol
611-36-9

quinolin-4-ol

Conditions
ConditionsYield
With copper(l) iodide; 1,8-diazabicyclo[5.4.0]undec-7-ene In acetonitrile at 20℃; for 6h; Reagent/catalyst; Solvent; chemoselective reaction;57%
Quinoline N-oxide
1613-37-2

Quinoline N-oxide

A

quinoline
91-22-5

quinoline

B

quinolin-4-ol
611-36-9

quinolin-4-ol

C

2,2'-biquinoline
119-91-5

2,2'-biquinoline

D

4-(quinolin-4-yl)quinoline
27080-08-6, 34281-95-3

4-(quinolin-4-yl)quinoline

Conditions
ConditionsYield
With naphthalene In tetrahydrofuran for 24h;A n/a
B 32%
C 20%
D n/a
Quinoline N-oxide
1613-37-2

Quinoline N-oxide

dichloroacethyl chloride
79-36-7

dichloroacethyl chloride

A

2-(dichloromethyl)quinoline
4032-52-4

2-(dichloromethyl)quinoline

B

quinolin-4-ol
611-36-9

quinolin-4-ol

C

bis(2-quinolyl)dichloromethane
88237-18-7

bis(2-quinolyl)dichloromethane

Conditions
ConditionsYield
With triethylamine In chloroform 2 h, r.t; 9 h;A 12.4%
B 4.6%
C 5.4%
Quinoline N-oxide
1613-37-2

Quinoline N-oxide

A

2-(dichloromethyl)quinoline
4032-52-4

2-(dichloromethyl)quinoline

B

quinolin-4-ol
611-36-9

quinolin-4-ol

C

bis(2-quinolyl)dichloromethane
88237-18-7

bis(2-quinolyl)dichloromethane

Conditions
ConditionsYield
With dichloroacethyl chloride; triethylamine In chloroform 2 h, r.t; 9 h;A 12.4%
B 4.6%
C 5.4%
4(1H)-quinolinone
529-37-3

4(1H)-quinolinone

quinolin-4-ol
611-36-9

quinolin-4-ol

Conditions
ConditionsYield
In chloroform Thermodynamic data; Equilibrium constant; ΔRGo, tests in solvents of different polarity;
2,3-dihydroquinolin-4(1H)-one
4295-36-7

2,3-dihydroquinolin-4(1H)-one

water
7732-18-5

water

palladium/charcoal

palladium/charcoal

quinolin-4-ol
611-36-9

quinolin-4-ol

methanol
67-56-1

methanol

1-hydroxyquinoline-4(1H)-one
72812-97-6

1-hydroxyquinoline-4(1H)-one

Raney nickel

Raney nickel

quinolin-4-ol
611-36-9

quinolin-4-ol

Conditions
ConditionsYield
Hydrogenation;
at 40 - 55℃; under 18387.7 Torr; Hydrogenation;
tetrachloromethane
56-23-5

tetrachloromethane

1-hydroxyquinoline-4(1H)-one
72812-97-6

1-hydroxyquinoline-4(1H)-one

phosphorus trichloride
7719-12-2, 52843-90-0

phosphorus trichloride

A

4-chloroquinoline
611-35-8

4-chloroquinoline

B

quinolin-4-ol
611-36-9

quinolin-4-ol

1-hydroxyquinoline-4(1H)-one
72812-97-6

1-hydroxyquinoline-4(1H)-one

chloroform
67-66-3

chloroform

phosphorus trichloride
7719-12-2, 52843-90-0

phosphorus trichloride

A

4-chloroquinoline
611-35-8

4-chloroquinoline

B

quinolin-4-ol
611-36-9

quinolin-4-ol

1-hydroxyquinoline-4(1H)-one
72812-97-6

1-hydroxyquinoline-4(1H)-one

ethyl acetate
141-78-6

ethyl acetate

phosphorus trichloride
7719-12-2, 52843-90-0

phosphorus trichloride

A

4-chloroquinoline
611-35-8

4-chloroquinoline

B

quinolin-4-ol
611-36-9

quinolin-4-ol

kynuramine
363-36-0

kynuramine

quinolin-4-ol
611-36-9

quinolin-4-ol

Conditions
ConditionsYield
With mouse brain monoamine oxidase-B Enzyme kinetics;
In aq. phosphate buffer at 37℃; for 0.333333h;
Kynuramine dihydrobromide

Kynuramine dihydrobromide

quinolin-4-ol
611-36-9

quinolin-4-ol

Conditions
ConditionsYield
With human recombinant monoamine oxidase-A GST fusion protein; Soerensen-phosphate buffer at 30℃; Enzyme kinetics;
cycl-isopropylidene malonate
2033-24-1

cycl-isopropylidene malonate

aniline
62-53-3

aniline

quinolin-4-ol
611-36-9

quinolin-4-ol

Conditions
ConditionsYield
Stage #1: cycl-isopropylidene malonate With orthoformic acid triethyl ester at 145℃;
Stage #2: aniline at 50 - 145℃;
Stage #3: In diphenylether at 250℃;
4-chloroquinoline
611-35-8

4-chloroquinoline

quinolin-4-ol
611-36-9

quinolin-4-ol

kynuramine

kynuramine

quinolin-4-ol
611-36-9

quinolin-4-ol

Conditions
ConditionsYield
With potassium chloride at 37℃; pH=7.4; Kinetics; Reagent/catalyst; Enzymatic reaction;
aniline
62-53-3

aniline

quinolin-4-ol
611-36-9

quinolin-4-ol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: ethanol / 2 h / Reflux
2: tetrahydrofuran / 0.03 h / 300 °C / 75007.5 Torr / Flash vacuum pyrolysis; Autoclave
View Scheme
Multi-step reaction with 4 steps
1: 1 h / Reflux
2: diphenylether / 1 h / Reflux
3: sodium hydroxide / 1 h / Reflux
4: diphenylether / 1 h / Reflux
View Scheme
methylene blue
152071-32-4

methylene blue

A

tryptamine
61-54-1

tryptamine

B

quinolin-4-ol
611-36-9

quinolin-4-ol

C

2-amino-4-(2-formamidophenyl)-4-oxo-butanoic acid
1022-31-7

2-amino-4-(2-formamidophenyl)-4-oxo-butanoic acid

D

Kynurenine
343-65-7

Kynurenine

Conditions
ConditionsYield
With Saccharomyces cerevisiae wild type strain V328 for 0.333333h; UV-irradiation;
naproxen
23981-80-8

naproxen

A

tryptamine
61-54-1

tryptamine

B

quinolin-4-ol
611-36-9

quinolin-4-ol

Conditions
ConditionsYield
With Saccharomyces cerevisiae wild type strain V328 for 0.333333h; UV-irradiation;
diethyl (anilinomethylene)malonate
54535-22-7

diethyl (anilinomethylene)malonate

quinolin-4-ol
611-36-9

quinolin-4-ol

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: diphenylether / 1 h / Reflux
2: sodium hydroxide / 1 h / Reflux
3: diphenylether / 1 h / Reflux
View Scheme
ethyl 4-hydroxy-3-quinolinecarboxylate
26892-90-0

ethyl 4-hydroxy-3-quinolinecarboxylate

quinolin-4-ol
611-36-9

quinolin-4-ol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium hydroxide / 1 h / Reflux
2: diphenylether / 1 h / Reflux
View Scheme
2-aminoacetophenone
551-93-9

2-aminoacetophenone

quinolin-4-ol
611-36-9

quinolin-4-ol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
2: copper(l) iodide; 1,8-diazabicyclo[5.4.0]undec-7-ene / acetonitrile / 6 h / 20 °C
View Scheme
2-[(trimethylsilyl)ethynyl]aniline
103529-16-4

2-[(trimethylsilyl)ethynyl]aniline

quinolin-4-ol
611-36-9

quinolin-4-ol

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: potassium carbonate / methanol / 12 h / 20 °C
2: hydrogenchloride; cetyltrimethylammonim bromide / water / 12 h / 80 °C
4: copper(l) iodide; 1,8-diazabicyclo[5.4.0]undec-7-ene / acetonitrile / 6 h / 20 °C
View Scheme
2-ethynylaniline
52670-38-9

2-ethynylaniline

quinolin-4-ol
611-36-9

quinolin-4-ol

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydrogenchloride; cetyltrimethylammonim bromide / water / 12 h / 80 °C
3: copper(l) iodide; 1,8-diazabicyclo[5.4.0]undec-7-ene / acetonitrile / 6 h / 20 °C
View Scheme
2-iodophenylamine
615-43-0

2-iodophenylamine

quinolin-4-ol
611-36-9

quinolin-4-ol

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: triethylamine; bis-triphenylphosphine-palladium(II) chloride; copper(l) iodide / tetrahydrofuran / 12 h / 20 °C / Inert atmosphere
2: potassium carbonate / methanol / 12 h / 20 °C
3: hydrogenchloride; cetyltrimethylammonim bromide / water / 12 h / 80 °C
5: copper(l) iodide; 1,8-diazabicyclo[5.4.0]undec-7-ene / acetonitrile / 6 h / 20 °C
View Scheme
quinolin-4-ol
611-36-9

quinolin-4-ol

3-bromo-4-hydroxyquinoline
64965-47-5

3-bromo-4-hydroxyquinoline

Conditions
ConditionsYield
With N-Bromosuccinimide In water; dimethyl sulfoxide for 24h;97%
With bromine; acetic acid
quinolin-4-ol
611-36-9

quinolin-4-ol

4-bromoquinoline
3964-04-3

4-bromoquinoline

Conditions
ConditionsYield
With boron tribromide In N,N-dimethyl-formamide Inert atmosphere;96%
With phosphorus tribromide In N,N-dimethyl-formamide at 20℃; for 0.5h;92%
With phosphorus tribromide In N,N-dimethyl-formamide for 0.666667h; Inert atmosphere;88%
quinolin-4-ol
611-36-9

quinolin-4-ol

4-methoxymethoxy-1-butanol
101992-89-6

4-methoxymethoxy-1-butanol

4-(4-methoxymethoxybutoxy)quinoline

4-(4-methoxymethoxybutoxy)quinoline

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 20℃; for 1h; Inert atmosphere;96%
quinolin-4-ol
611-36-9

quinolin-4-ol

4-hydroxy-6-nitro-quinoline
23432-42-0

4-hydroxy-6-nitro-quinoline

Conditions
ConditionsYield
With sulfuric acid; nitric acid In water at -15 - 20℃; for 3h;95%
With sulfuric acid; nitric acid at -15 - 0℃; for 2h;84%
Stage #1: quinolin-4-ol With sulfuric acid; nitric acid at 0 - 5℃; Cooling with ice;
Stage #2: at 20℃; for 2h;
63%
quinolin-4-ol
611-36-9

quinolin-4-ol

1,2-bis(4-methylphenyl)acetylene
2789-88-0

1,2-bis(4-methylphenyl)acetylene

5,6-di-p-tolylpyrano[2,3,4-de]quinoline

5,6-di-p-tolylpyrano[2,3,4-de]quinoline

Conditions
ConditionsYield
With silver hexafluoroantimonate; dichloro(pentamethylcyclopentadienyl)rhodium (III) dimer; copper diacetate; lithium trifluoromethanesulfonate In 1,2-dimethoxyethane at 100℃; for 12h; Schlenk technique; Inert atmosphere;95%
quinolin-4-ol
611-36-9

quinolin-4-ol

benzoyl chloride
98-88-4

benzoyl chloride

4-(benzoyloxy)quinoline
81336-57-4

4-(benzoyloxy)quinoline

Conditions
ConditionsYield
With 4-methyl-morpholine In dichloromethane at 10 - 25℃;94%
With 4-methyl-morpholine In dichloromethane at 20℃; for 3h;
In dichloromethane at 20℃; for 3h;
quinolin-4-ol
611-36-9

quinolin-4-ol

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

1-methanesulfonyl-4a,8a-dihydro-1H-quinolin-4-one

1-methanesulfonyl-4a,8a-dihydro-1H-quinolin-4-one

Conditions
ConditionsYield
With dmap In tetrahydrofuran at 20℃; for 2h;94%
quinolin-4-ol
611-36-9

quinolin-4-ol

benzyl alcohol
100-51-6

benzyl alcohol

4-(phenylmethoxy)quinoline
101273-58-9

4-(phenylmethoxy)quinoline

Conditions
ConditionsYield
With triphenylphosphine; diethylazodicarboxylate In tetrahydrofuran; toluene at 20 - 30℃; Mitsunobu Displacement; Inert atmosphere; regioselective reaction;94%

611-36-9Relevant academic research and scientific papers

HPLC-based bioactivity profiling of plant extracts: A kinetic assay for the identification of monoamine oxidase-A inhibitors using human recombinant monoamine oxidase-A

Dittmann, Kathrin,Riese, Ulrike,Hamburger, Matthias

, p. 2885 - 2891 (2004)

An assay for the HPLC-based search for monoamine oxidase-A (MAO-A) inhibitors in plant extracts was established. It combines human recombinant MAO-A, expressed as GST-fusion protein in yeast, with a kinetic measurement of the conversion of kynuramine to 4-hydroxyquinoline. Substrate selectivity and kinetic parameters of the GST-fusion protein were comparable to the wild-type enzyme. The applicability of the assay to HPLC-based activity profiling was tested with plant extracts spiked with small amounts of known MAO inhibitors.

1-methyl-2-undecyl-4(1H)-quinolone as an irreversible and selective inhibitor of type B monoamine oxidase.

Lee, Myung Koo,Hwang, Bang Yeon,Lee, Seon A,Oh, Gab Jin,Choi, Woo Hoi,Hong, Seong Su,Lee, Kyong Soon,Ro, Jai Seup

, p. 409 - 411 (2003)

The inhibitory compound of monoamine oxidase (MAO) activity was isolated from the CH(2)Cl(2) fraction of the fructus of Evodia rutaecarpa and identified as 1-methyl-2-undecyl-4(1H)-quinolone (1). Compound 1 showed a selective inhibition of type B MAO (MAO-B) activity with the IC(50) value of 15.3 microM using a substrate kynuramine, but did not inhibit type A MAO (MAO-A) activity. The kinetic analysis using Lineweaver-Burk plots indicated that compound 1 competitively inhibited MAO-B activity with the K(i) value of 9.91 microM. The inhibition of MAO-B by compound 1 was found to be irreversible by dialysis of the incubation mixture. These results suggest that compound 1 is a potent irreversible inhibitor of MAO-B, and may regulate catecholamine content in the neurons.

In vitro monoamine oxidase inhibition potential of alpha-methyltryptamine analog new psychoactive substances for assessing possible toxic risks

Wagmann, Lea,Brandt, Simon D.,Kavanagh, Pierce V.,Maurer, Hans H.,Meyer, Markus R.

, p. 84 - 93 (2017)

Tryptamines have emerged as new psychoactive substances (NPS), which are distributed and consumed recreationally without preclinical studies or safety tests. Within the alpha-methylated tryptamines, some of the psychoactive effects of the prototypical alpha-methyltryptamine (AMT) have been described decades ago and a contributing factor of its acute toxicity appears to involve the inhibition of monoamine oxidase (MAO). However, detailed information about analogs is scarce. Therefore, thirteen AMT analogs were investigated for their potential to inhibit MAO. An in vitro assay analyzed using hydrophilic interaction liquid chromatography–high resolution-tandem mass spectrometry was developed and validated. The AMT analogs were incubated with recombinant human MAO-A or B and kynuramine, a non-selective MAO substrate to determine the IC50values. The known MAO-A inhibitors 5-(2-aminopropyl)indole (5-IT), harmine, harmaline, yohimbine, and the MAO-B inhibitor selegiline were tested for comparison. AMT and all analogs showed MAO-A inhibition properties with IC50values between 0.049 and 166?μM, whereas four analogs inhibited also MAO-B with IC50values between 82 and 376?μM. 7-Me-AMT provided the lowest IC50value against MAO-A comparable to harmine and harmaline and was identified as a competitive MAO-A inhibitor. Furthermore, AMT, 7-Me-AMT, and nine further analogs inhibited MAO activity in human hepatic S9 fraction used as model for the human liver which expresses both isoforms. The obtained results suggested that MAO inhibition induced by alpha-methylated tryptamines might be clinically relevant concerning possible serotonergic and adrenergic effects and interactions with drugs (of abuse) particularly acting as monoamine reuptake inhibitors. However, as in vitro assays have only limited conclusiveness, further studies are needed.

Copper-Catalyzed Chemoselective Cyclization Reaction of 2-Isocyanoacetophenone: Synthesis of 4-Hydroxyquinoline Compounds

Yuan, Qing,Rao, Weidong,Wang, Shun-Yi,Ji, Shun-Jun

, p. 1279 - 1284 (2020/01/22)

A copper-catalyzed intramolecular cyclization reaction of 2-isocyanoacetophenone derivatives to afford 4-hydroxyquinolines chemoselectively is described. The transformation proceeds through enol tautomerism and a subsequent C-C bond formation. Compared to previous methods, this study provides a new protocol for the construction of 4-hydroxyquinoline compounds from functionalized isocyanides under mild conditions.

Combining 1,3-Ditriazolylbenzene and Quinoline to Discover a New G-Quadruplex-Interactive Small Molecule Active against Cancer Stem-Like Cells

Mendes, Eduarda,Cadoni, Enrico,Carneiro, Filipa,Afonso, Marta B.,Brito, Hugo,Lavrado, Jo?o,dos Santos, Daniel J. V. A.,Vítor, Jorge B.,Neidle, Stephen,Rodrigues, Cecília M. P.,Paulo, Alexandra

supporting information, p. 1325 - 1328 (2019/06/21)

Quadruplex nucleic acids are promising targets for cancer therapy. In this study we used a fragment-based approach to create new flexible G-quadruplex (G4) DNA-interactive small molecules with good calculated oral drug-like properties, based on quinoline

Photoreductive Removal of O-Benzyl Groups from Oxyarene N-Heterocycles Assisted by O-Pyridine-pyridone Tautomerism

Todorov, Aleksandar R.,Wirtanen, Tom,Helaja, Juho

, p. 13756 - 13767 (2017/12/26)

Facile photoreductive protocols have been developed to remove benzyl O-protective groups from oxyarene N-heterocycles at positions capable for 2-/4-O-pyridine-2-/4-pyridone tautomerism. Blue light irradiation, a [Ru] or [Ir] photocatalyst, and ascorbic acid in a water-acetonitrile solution debenzylates a variety of aryl N-heterocycles cleanly and selectively. Ascorbic acid has two functions in the reaction. On the one hand, it protonates the N-heterocycles that reduces their reduction potentials notably and on the other hand it acts as a sacrificial reductant. Reduction potentials and free energy barriers calculated at the CPCM-B3LYP/6-31+G? level can predict the reactivities of the studied substrates.

UVA photoinduced yeast protein modifications by methylene blue and naproxen

Bracchitta, Giuseppina,Catalfo, Alfio,De Guidi, Guido

, p. 967 - 973 (2013/09/12)

UVA photosensitization by methylene blue (MB) or by naproxen (NAP) towards cell proteins in yeast Saccharomyces cerevisiae was investigated in order to compare this system with two simpler models, such as free Trp in solution and as a component of bovine and human serum albumin. The process was studied by monitoring protein tryptophan (Trp) residue integrity. The sensitized photodegradation of proteins resulted in different degrees of Trp damage with different Trp (photo)-products. Indeed, many of these Trp derivatives are diagnostic for the photosensitization mechanism and some of them were obtained from cells by UVA photosensitization for the first time in this work. The analysis of quantum yields of photoproduct distribution allowed us to weigh up the type I/II contribution on a UVA photosensitization mechanism. The UVA mediated generation of these Trp derivatives is consistent with the occurrence of singlet oxygen formation (almost dominant in MB), and photoionization (significant in NAP) within the protein matrix. The results obtained in the case of this more complex system (cell) are in agreement with the two simpler models recently studied in our lab. The quantum yields of Trp photoinduced degradation, as well as of its photoproducts formation, decrease with increasing the complexity of the investigated target. The Royal Society of Chemistry and Owner Societies 2013.

Highly efficient thermal cyclization reactions of alkylidene esters in continuous flow to give aromatic/heteroaromatic derivatives

Lengyel, László,Nagy, Tibor Zs.,Sipos, Gellért,Jones, Richard,Dormán, Gy?rgy,ürge, László,Darvas, Ferenc

, p. 738 - 743 (2012/03/08)

Intramolecular thermal cyclization and benzannulation reactions of the Gould-Jacobs and Conrad-Limpach types were performed in a designed continuous flow reactor system at temperatures in the range of 300-360°C and under high pressure conditions (100-160 bar) with very short residence times (0.45-4.5 min) in tetrahydrofuran as a low-boiling point solvent. Substituted heteroaromatic compounds including pyridopyrimidinones and hydroxyquinolines were synthesized in moderate to high yields. Application of the reaction conditions also allows the synthesis of naphthol and biphenyl derivatives. The procedure involves an easy work-up and the non-batchwise preparative synthesis method is suitable for automation.

Inhibition of monoamine oxidase by 8-benzyloxycaffeine analogues

Strydom, Belinda,Malan, Sarel F.,Castagnoli Jr., Neal,Bergh, Jacobus J.,Petzer, Jacobus P.

experimental part, p. 1018 - 1028 (2010/04/26)

Based on recent reports that several (E)-8-styrylcaffeinyl analogues are potent reversible inhibitors of monoamine oxidase B (MAO-B), a series of 8-benzyloxycaffeinyl analogues were synthesized and evaluated as inhibitors of baboon liver MAO-B and recombinant human MAO-A and -B. The 8-benzyloxycaffeinyl analogues were found to inhibit reversibly both MAO isoforms with enzyme-inhibitor dissociation constants (Ki values) ranging from 0.14 to 1.30 μM for the inhibition of human MAO-A, and 0.023-0.59 μM for the inhibition of human MAO-B. The most potent MAO-A inhibitor was 8-(3-methylbenzyloxy)caffeine while 8-(3-bromobenzyloxy)caffeine was the most potent MAO-B inhibitor. The analogues inhibited human and baboon MAO-B with similar potencies. A quantitative structure-activity relationship (QSAR) study indicated that the MAO-B inhibition potencies of the 8-benzyloxycaffeinyl analogues are dependent on the Hansch lipophilicity (π) and Hammett electronic (σ) constants of the substituents at C-3 of the benzyloxy ring. Electron-withdrawing substituents with a high degree of lipophilicity enhance inhibition potency. These results are discussed with reference to possible binding orientations of the inhibitors within the active site cavities of MAO-A and -B.

Assembly of 4-aminoquinolines via palladium catalysis: A mild and convenient alternative to SNAr methodology

Margolis, Brandon J.,Long, Kimberly A.,Laird, Dana L. T.,Ruble, J. Craig,Pulley, Shon R.

, p. 2232 - 2235 (2007/10/03)

4-Aminoquinolines, classically prepared via SNAr chemistry from an amine and 4-haloquinoline, are important scaffolds in medicinal chemistry. Interest in these compounds prompted us to explore palladium catalysis as an alternative to the existing methods for their preparation. Initial results followed by an iterative screening paradigm confirmed Pd(OAc)2/ DPEphos/K3PO4 as a mild and convenient alternative for the formation of the C-N bond in 4-aminoquinolines. A description of the screen and the scope of this methodology are discussed herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 611-36-9